Reneo Pharmaceuticals (RPHM)
(Delayed Data from NSDQ)
$1.48 USD
-0.03 (-1.99%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $1.49 +0.01 (0.68%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 32.43% |
ABR | 3.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.83 |
Next Year | -0.38 |
EPS (TTM) | -2.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.07 | -0.83 | -0.38 |
# of Estimates | 2 | 1 | 3 | 1 |
Most Recent Consensus | -0.10 | -0.07 | -0.65 | NA |
High Estimate | -0.10 | -0.07 | -0.65 | -0.38 |
Low Estimate | -0.23 | -0.07 | -1.01 | -0.38 |
Year ago EPS | -0.65 | -0.57 | -2.52 | -0.83 |
Year over Year Growth Est. | 73.85% | 87.72% | 67.06% | 54.22% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.07 | -0.83 | -0.38 |
7 Days Ago | -0.17 | -0.07 | -0.83 | -0.38 |
30 Days Ago | -0.17 | -0.07 | -0.83 | -0.38 |
60 Days Ago | -0.17 | -0.07 | -0.83 | -0.38 |
90 Days Ago | -0.13 | -0.11 | -0.85 | -0.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.07 | -0.83 | -0.38 |
Zacks Consensus Estimate | -0.17 | -0.07 | -0.83 | -0.38 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.70 | -0.57 | -0.65 | NA |
Estimate | -0.37 | -0.55 | -0.60 | -0.55 | NA |
Difference | 0.12 | -0.15 | 0.03 | -0.10 | -0.03 |
Surprise | 32.43% | -27.27% | 5.00% | -18.18% | -2.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more